Trials / Enrolling By Invitation
Enrolling By InvitationNCT06476288
RIC (Remote Ischemic Conditioning) in Older Individuals
Feasibility and Acceptability of Remote Ischemic Conditioning to Achieve High-Intensity Rehabilitation Effects and Increase Resilience in Older Individuals
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the feasibility and acceptability of a technique called remote ischemic conditioning (RIC) that aims to improve muscle strength, muscle mass, exercise tolerance, resilience (i.e. how well someone responds to a stressor), quality of life, physical activity, and physical function when added to rehabilitative exercise training in individuals over age 65 who have some difficulty with mobility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Low-intensity resistance exercise training | The intervention protocol will consist of 60 minutes of low-intensity resistance exercise training 3x/week for 6 weeks. |
| OTHER | High-Dose Remote ischemic conditioning (RIC) | Treatment dose of RIC- the RIC cuff will be inflated to 20 mmHg over the participant's systolic blood pressure. The treatment dose of RIC will be applied in 4 sets of cycles with inflating the cuff and leaving it pumped for 5 minutes then deflating the cuff for an off period of 5 minutes. Total treatment time will be 35 minutes. |
| OTHER | Low-Dose Remote ischemic conditioning (RIC) | This dose will be the control for the study. Low-dose RIC- the RIC cuff will be inflated to 10 mmHg below the participant's diastolic blood pressure. The low-dose RIC will be applied in 4 sets of cycles with inflating the cuff and leaving it pumped for 5 minutes then deflating the cuff for an off period of 5 minutes. Total treatment time will be 35 minutes. |
Timeline
- Start date
- 2024-09-30
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
- First posted
- 2024-06-26
- Last updated
- 2025-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06476288. Inclusion in this directory is not an endorsement.